📊 Unexpected Surges, Silent Climbers, and a $100M Mining Play

Good Morning Investors,

Yesterday was full of surprise moves and silent rallies. I-Mab $IMAB ( ▲ 7.3% ) led the charge with no press release, no headline, just a sharp move that turned heads.

NET Power $NPWR ( ▼ 8.9% ) followed with a jump fueled by a wave of legal alerts that stirred up investor interest. Rekor $REKR ( ▼ 6.45% ) and Compugen $CGEN ( ▼ 0.61% ) also posted strong gains with no clear catalyst.

But the most concrete mover? Americas Gold and Silver $USA.TSX ( ▼ 3.64% ), which surged after announcing a $100 million debt financing package alongside a multi-metal off take agreement.

Here’s what moved. 👇

Matthias Schneider
Editor at Analytica Investor

↑ ↓ 1-day change
Market data: Yesterday’s market close

The small-cap sector experienced a healthy uptick yesterday, with the Russell 2000 and S&P/TSX Venture Composite Index seeing gains of 1.6% and 1.4% respectively. NASDAQ Composite also enjoyed a 0.8% increase. Secondary indices showed positive trends in the semiconductor and IT sectors, while the Energy sector experienced a 1.1% surge.

The recent rise in tariffs on steel and aluminum imports by 50%, as implemented by President Trump, caused stir in the markets, eliciting caution from analysts (CNBC, Market Watch). Despite this, an unexpected increase in US jobs triggered a boost in stocks (Bloomberg, Seeking Alpha ).

The trading environment for small-cap stocks remains ambiguous due several factors including the recent tariffs and economic data shocks. These factors alongside a "No Hire, No Fire Economy" have raised alarms for analysts (CNBC, Schwab Network). Despite these concerns, there are suggestions of an impending market upturn along with potential for small-cap stocks to outperform (CNBC, Yahoo Finance).

The aerospace sector warned that new US tariffs could put air safety and supply chain at risk (Reuters), and an impending trade war has been projected to derail global economic growth (NYTimes).

Looking forward, investors should remain attentive to subtleties in the market trends. The economic impact of the tariffs, Federal Reserve policy, and performance of various sectors continue to shape the landscape for small-cap stocks.

A Word From Our Partner

A New Chapter in Home Construction

What if new-home construction were nearly as easy as opening a book? That’s the story with BOXABL.

How? By using assembly lines to condense homebuilding from 7+ months to hours, BOXABL ships readymade houses to their final destination. Then, they’re unfolded and immediately livable.

They’ve already built 700+. But the real transformation’s still coming.

BOXABL’s currently preparing for Phase 2 – combining modules into larger townhomes, single-family homes, and apartments. And until 6/24, you can join as an investor for just $0.80/share.

They already fully maxed out a $75M investment campaign once, so don’t wait around.

Invest in BOXABL Now

_{*This is a paid advertisement for Boxabl’s Regulation A offering. Please read the offering circular at https://invest.boxabl.com/#circular}

📈 Biggest Gainers 

• I-Mab ($IMAB NASDAQ) - 46%: 
  Market Cap: 152,704,759
  
  A clinical stage biopharmaceutical company that researches, develops, and commercializes biologics for treating cancer and autoimmune disorders.

• Rekor Systems, Inc. ($REKR NASDAQ) - 31%:
  Market Cap: 170,029,440
  
  Develops and implements intelligent infrastructure solutions and services for transportation management, public safety, and commercial markets primarily in North America.

• NET Power Inc. ($NPWR NYSE) - 24%: 
  Market Cap: 214,526,244
  
  This clean energy technology company invents, develops, and licenses clean power generation technology, based in Durham, North Carolina since 2010.
  
  The recent 24% change in stock price is a direct result of multiple public relations releases announcing class action lawsuits against the company, deadlines for investors to join these lawsuits, and encouragement for shareholders who have faced losses to secure legal counsel. (1, 2, 3)

• Compugen Ltd. ($CGEN NASDAQ) - 22%: 
  Market Cap: 171,128,790
  
  Researches, develops, and commercializes therapeutic candidates for solid tumors, advanced malignancies and non-small cell lung cancer in Israel, the US, and Europe.

• Northann Corp. ($NCL AMEX) - 20%:
  Market Cap: 108,829,416
  
  Specializing in manufacturing, wholesaling, and retailing 3D printed vinyl flooring panels globally under the Benchwick brand from California since 2013.

• Americas Gold and Silver Corporation ($USAS AMEX) - 19%:
  Market Cap: 498,726,927
  
  This corporation explores and develops mineral properties in North America, primarily focused on silver, lead, zinc, copper, and gold deposits.
  
  The recent 19% rise in stock price was significantly influenced by the announcement of a transformative US$100 million debt financing and the securing of a multi-metal offtake agreement for Galena concentrates. (1)

📉 Biggest Loser

• Webull Corporation Incentive Warrant ($BULLZ NASDAQ) - -22%: 
  Market Cap: 167,096,642
  
  This digital platform offers trading services, wealth management products, market data, user community, and investor education.

🚀 Biggest Movers

• Plug Power Inc. ($PLUG NASDAQ) - 186,495,355 shares traded with an average volume of 102,924,498 (10%): 
  Market Cap: 982,152,072
  
  Delivers clean hydrogen and zero-emissions fuel cell solutions for various applications, and builds an end-to-end green hydrogen ecosystem globally.

• Opendoor Technologies Inc. ($OPEN NASDAQ) - 72,187,566 shares traded with an average volume of 59,921,773 (-1%): 
  Market Cap: 430,559,458
  
  This American company operates a digital platform for buying, selling residential real estate and also offers title insurance and escrow services.

• Tilray Brands, Inc. ($TLRY NASDAQ) - 66,556,443 shares traded with an average volume of 27,355,762 (-2%):
  Market Cap: 410,622,212
  
  Engages in the cultivation, production, and global distribution of medical cannabis, pharmaceutical, wellness, and beverage alcohol products.
  
  The stock's recent 2% decrease in price is largely due to the partnership announcement between SweetWater Brewing and Zoo Atlanta as well as the company's presentation at the TD Cowen's 9th Annual Future of the Consumer Conference, which failed to inspire investor confidence. (1, 2)

🏦 Recent & Relevant IPOs

JENA ACQUISITION Corp II ($JENAU) leads recent small-cap IPOs, debuting on the NYSE with a robust market cap of $200 million.

• Fuxing China Group Limited ($FFFZ) on NASDAQ (2025-05-29). Market Cap: $10,350,000

• JENA ACQUISITION Corp II ($JENAU) on NYSE (2025-05-29). Market Cap: $200,000,000

• Wintergreen Acquisition Corp. ($WTGUU) on NASDAQ (2025-05-29). Market Cap: $50,000,000

• Pitanium Limited $PTNM on NASDAQ (2025-05-30). Market Cap: $7,000,000

Post Of The Day

👀 Stocks To Add To Your Watchlist

$FENC ( ▼ 1.27% ) · NASDAQ Capital Market — Fennec Pharmaceuticals Inc.
Healthcare/Biotechnology
YTD: +25.278%
Market Cap: $217,497,263

Showcases a potentially lucrative opportunity as it navigates the biotech industry with its flagship product, PEDMARK, aimed at preventing platinum-induced ototoxicity in pediatric cancer patients.

Despite the market's volatility post-tariff implementations, FENC exhibits resilience with a recent spike in stock price, highlighted by a robust 11.84% increase on May 19, 2025. Coupled with insider confidence, as demonstrated by recent share acquisitions by company executives and directors, FENC positions itself as an attractive prospect for investors eyeing growth in the healthcare sector.

$DMRC ( ▼ 1.4% ) · NASDAQ Global Select — Digimarc Corporation
Technology/Information Technology Services
YTD: -65.846%
Market Cap: $295,908,960

Despite facing a flurry of class action lawsuits, Digimarc Corporation (NASDAQ: DMRC) has showcased resilience with a notable close of $13.73, marking a significant 4.25% increase as of June 3, 2025.

This uptick follows a period of volatility in the stock's performance but aligns with the broader technology sector's positive momentum. Investors should closely monitor the company's legal developments and potential impacts on stock performance, considering the volatile nature of its recent trading activity.

$DBVT ( ▼ 4.57% ) · NASDAQ Global Select — DBV Technologies S.A. Healthcare/Biotechnology
YTD: +144.308%
Market Cap: $217,108,954

DBVT has demonstrated resilience amidst recent market volatility, particularly within the healthcare sector. With its lead product, Viaskin Peanut, having completed Phase III clinical trials for peanut allergies and various other products in the pipeline, DBVT is an intriguing watch.

Despite a challenging end to the month with a 9.77% drop on May 20th, the stock rebounded 5.17% on June 3rd. This volatility might offer speculative opportunities, especially as the company progresses towards FDA approval and commercial launch aspirations.

$OM ( ▼ 3.02% ) · NASDAQ Global Select — Outset Medical, Inc. 
Healthcare/Medical - Devices
YTD: +10.598%
Market Cap: $343,989,843

Demonstrating a robust potential in the medical devices sector, especially with its innovative Tablo Hemodialysis System. Since its IPO in 2020, the company has shown significant strides in technology, leading to a recent uptick in stock value.

The appointment of Renee Gaeta as CFO and the strong first-quarter results highlighting growth in console and recurring revenue, alongside expanded gross margin and reduced cash use, signal a solid financial and operational footing. Despite recent market volatility, Outset Medical's stock has experienced an impressive rally, making it a noteworthy consideration for investors interested in healthcare innovation.

$MGNX ( ▼ 4.38% ) · NASDAQ Global Select — MacroGenics, Inc. 
Healthcare/Biotechnology
YTD: -54.242%
Market Cap: $95,266,353

A biopharmaceutical firm specializing in antibody-based cancer therapies, remains a noteworthy pick in the healthcare sector. Recently, its stock experienced an 8.63% upswing, signaling growing investor interest.

With its broad pipeline including MARGENZA for HER2-positive breast cancer and ongoing advancements in solid tumors and hematologic malignancies, MGNX demonstrates promising potential for growth. Insider activities further bolster confidence, with notable purchases underscoring management's optimism. As such, MGNX offers an intriguing opportunity for investors attentive to the biotech space.

That’s it for this episode!

Thank you for taking the time to read today’s email! Your support is what allows me to send out this newsletter for free every week. 

Disclaimer: This newsletter is for informational purposes only and contains forward-looking statements that involve risks and uncertainties. Investor Insights Systems does not provide financial advice—please consult a licensed advisor before making investment decisions.